1,290 press releases in English indexed under real estate.
Rafi Toledano's Sorrento Property Group closed $103M in sales across four states this year, with a $60M Jacksonville deal set to close by year-end.
Aaron B. Latto Shawn V. Los CINCINNATI, October 27, 2026--Great American Insurance Group is pleased to announce the promotions of Jason M. Cohen and Aaron B. Latto to Executive Vice President and Shawn V. Los to Senior Vice President. Mr. Cohen joined the company in 2006 as Divisional Vice President wi
SiteAI turns the agent, team or brokerage website from a digital introduction into an interactive resource for consumers. EL SEGUNDO, CA / October 27, 2026 / Agent Image today announced SiteAI, a patent-pending conversational commerce platform that lets visitors to real estate websites ask questions in t
Foreclosure Deals - One Easy Search Tallahassee Realtor LaTasha McDowell discusses overlooked property types, alternative financing and steps for homebuyers navigating affordability challenges. BOCA RATON, FL, UNITED STATES, October 27, 2026 / EINPresswire.com / -- Foreclosure.com has published a new interview featuring LaTasha McDowell, a REALTOR® and Certified Real Estate Instructor based in Tallahassee, Florida, e
DealNav 3.0 shows the county record for any lot on the map, including owner, last sale, zoning and assessed values. The map-based CRM adds full county records to every lot on the map, and lets teams ask their AI assistant about their own pipeline, from $59 a month. DealNav 3.0 puts the parcel, the owner, the deal and the follow-up in one place, and lets you ask your AI assistant about it, at a price any shop can just
ORLANDO, FL, UNITED STATES, October 27, 2026 / EINPresswire.com / -- Success Orlando, a tax planning and financial advisory firm serving business owners, entrepreneurs, and real estate investors, has been named a 2026 Best of Florida Award winner, recognizing the firm's commitment to proactive, personalized financial guidance across the greater Orlando area. Known for its comprehensive approach to tax and financial s
A new Paranova data brief compares housing age across Central Arkansas and offers a free worksheet for checking repair costs before a sale. LITTLE ROCK, AR, UNITED STATES, October 27, 2026 / EINPresswire.com / -- LITTLE ROCK, Ark. — A new Paranova Property Buyers data brief finds that an estimated 49.7% of Pulaski County's owner-occupied housing units were built before 1980, compared with 37.5% statewide. The figures
SASKATOON, SASKATCHEWAN - October 27, 2026 - Omineca Mining and Metals Ltd. (TSXV: OMM) (“Omineca” or the “Company”) is pleased to announce that in the matter of the declared, voluntary bankruptcy of D&L Mining Corp (see news release October 9th, 2026), the Licensed Insolvency Trustee, MNP Ltd., has disclaimed/quit claimed D&L’s interest in the Wingdam underground project. Since receiving this notice, Omineca has taken steps to secure management of the mine site in order to provide continuity of operations. In support of these measures, Omineca has engaged PSI Mining of Saskatoon, Saskatchewan to assume temporary operating responsibility for the Wingdam placer project. This significant outcome returns full control of the Wingdam Paleoplacer project to Omineca, allowing management to complete an agreement directly with a development partner prepared to advance the project without delay. About Omineca Mining and Metals Ltd. Wingdam, BC Omineca’s flagship Wingdam hard rock exploration and placer gold recovery projects are located along the Barkerville Highway 45 km east of the City of Quesnel. The Wingdam Property includes mineral tenures totaling 61,392 hectares (613 square kms) and in excess of 15 linear kilometers of placer claims, both encompassing the Lightning Creek valley where topographic conditions created thick layers of overburden, which preserved a large portion of a buried paleochannel containing placer gold-bearing gravels. Omineca also has a program exploring for the potential multiple hard rock sources of the placer gold at Wingdam. Fraser Canyon, BC Part of Omineca’s original acquisitions in the Cariboo Mining District, the Fraser Canyon Project located 12 kilometers northwest of Quesnel, BC, is now slated to reinitiate the development of the underground paleochannel for the recovery of placer gold. Historically, two mines north and south of the Fraser River collectively produced 1,482 oz of raw placer gold. For further information, please contact: Tom MacNeill President and CEO 306-653-2692 Forward Looking Statements: This release includes forward-looking statements regarding Omineca and its business. Such statements are based on the current expectations and views of future events of Omineca’s management. In some cases, the forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify forward-looking statements. The forward-looking events and circumstances discussed in this release may not occur and could differ materially with other factors beyond the control of Omineca. No forward-looking statement can be guaranteed. Forward-looking statements and information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement or information. Accordingly, readers should not place undue reliance on any forward-looking statements or information. Forward-looking statements speak only as of the date on which they are made and Omineca undertakes no obligation to publicly Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Winners in the expanded program, which now includes Inman's Best of AI honors, will be announced Thursday, Oct. 29. TALLAHASSEE, Fla., Oct. 27, 2026 -- Inman, the leading news source for real estate agents, brokers, executives and technology leaders, today named the...
Planned Drill Program Would be the First Drilling at Eagle Point in More Than 70 Years VANCOUVER, BC - October 27, 2026 - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (FRA: 4K2) (the "Company" or "Western Star") is pleased to announce that on October 22, 2026, a 43 CFR 3809 Exploration Notice (the "Notice") was submitted to the U.S. Bureau of Land Management ("BLM") Las Cruces District Office for its Eagle Point Tungsten Project ("Eagle Point" or the "Property") in Hidalgo County, New Mexico. The Notice, prepared and filed on the Company's behalf by KC Harvey Environmental, LLC, covers a tungsten exploration program of 17 HQ core holes from 12 drill pads, approximately 0.56 mile of temporary connector roads and one laydown area, for a total of 1.71 acres of surface disturbance on BLM-administered and private land. Submission of the Notice is a key step toward the Company's planned 17-hole, approximately 6,000-foot drill program, which the Company believes will be the first drilling at Eagle Point in more than 70 years. Drill targets were refined using the results of the Company's 2026 surface mapping and sampling program, as reported in its news release dated September 30, 2026. Blake Morgan, CEO and President of Western Star, stated, "Filing our Exploration Notice moves Eagle Point from field mapping and exploration, to only weeks away drilling. Our 2026 surface work gave us clear targets along the granite contact, and this program is designed to test them beneath surface exposures and talus cover. We appreciate the work of KC Harvey Environmental in preparing the submission and look forward to working with the BLM as we advance a domestic tungsten project at a time when secure U.S. supply has become a national priority." Key Highlights: Notice submitted: A 43 CFR 3809 Exploration Notice was filed with the BLM Las Cruces District Office on October 22, 2026, covering five lode claims in Section 22, T29S R16W, New Mexico Principal Meridian, Hidalgo County. Drill program: 17 HQ core holes from 12 drill pads, totalling approximately 6,000 feet, with planned hole depths of 164 to 820 feet, designed to test the steeply dipping skarn contact. Small footprint: Total proposed surface disturbance is 1.71 acres, including the 12 drill pads, approximately 0.56 mile of temporary connector roads and a single laydown area. All new disturbance will be reclaimed concurrently with the program. Surface access secured: Western Star has a surface use agreement in place with the private surface owner covering road access and all proposed activities on private land. Program preparation underway: The Company is tendering drilling contractors and setting up logistics for the program. Exploration Notice Details The Notice was submitted under the BLM's surface management regulations at 43 CFR Subpart 3809, which govern exploration on federal mining claims. The submission includes location, access and project layout figures, claims information, a typical drill pad layout, and GIS shapefiles for the drill pads, roads, laydown area and claim boundary. Eight of the 12 drill pads, the laydown area and most of the connector roads are on private surface, accounting for approximately 1.35 acres of the proposed disturbance. The remaining four pads and approximately 565 feet of connector road are on BLM-administered land, accounting for approximately 0.36 acres. The Project area is accessed by approximately 3.3 miles of existing roads from U.S. Highway 81, which will be used without upgrades. Drilling will use a water-based fluid recirculated through a closed-loop centrifuge system, so no in-ground sumps or mud pits are proposed. Drilling water will be purchased from a commercial supplier and trucked to site, with no on-site well or surface water diversion. Each hole will be plugged and abandoned on completion, and drill pads, connector roads and the laydown area will be recontoured, topsoiled and seeded. Figure 1: Location and access overview of the Eagle Point Tungsten Project, Hidalgo County, New Mexico, showing the access route from U.S. Highway 81, surface management, the mining claim boundary and the proposed drill pads. Figure 2: Eagle Point project layout, showing the 17 proposed drill hole locations (EP26-001 to EP26-017) on 12 drill pads, temporary connector roads, laydown area LD-1 and the existing access road. Next Steps The Notice describes an operating period from December 2026 through December 2027. Before drilling begins, the Company will submit a Minimal Impact Exploration Operation permit application to the New Mexico Mining and Minerals Division and well and plugging filings to the New Mexico Office of the State Engineer, and will post a reclamation financial guarantee, which is anticipated to be held jointly by the BLM and the Mining and Minerals Division. The Company will also provide the BLM with supplemental vegetation documentation and the results of a cultural resources file search and site inventory. In parallel, Western Star is tendering drilling contractors, setting up field logistics and finalizing collar locations using its Leapfrog Geo model. No Mineral Resource has been established at Eagle Point. Qualified Person The scientific and technical information contained in this news release has been reviewed and approved by Jacob Anderson, CPG (#12160), MAusIMM (#3089445), an independent consultant to the Company and a Qualified Person as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects. Mr. Anderson is independent of the Company. About Western Star Resources Western Star Resources is a mineral exploration company focused on the acquisition, exploration and advancement of mineral properties, with a growing strategic emphasis on tungsten and critical minerals in the United States. The Company is advancing a portfolio of past-producing tungsten assets in Nevada and New Mexico while maintaining additional exploration exposure through its Western Star property in British Columbia. Contact Information On behalf of the Board of Directors, Blake Morgan, Director, President and CEO blake@acvc.vc Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this press release. Forward-looking information: Certain statements herein may constitute forward-looking information, including references to the BLM's review of the Exploration Notice, state permit applications, the posting of a reclamation financial guarantee, the timing, scope and completion of the planned drill program, and future exploration work. Such statements are subject to risks associated with regulatory review and permitting, land access, exploration, operations, weather, and contractor and equipment availability. Forward-looking information is based on the Company's current expectations and assumptions, including that regulatory reviews will be completed on a timely basis, that required approvals and financial guarantees will be obtained on acceptable terms, and that drilling contractors and equipment will be available as planned. Readers are advised not to place undue reliance on forward-looking information. The Company does not undertake to update forward-looking information except as required by applicable securities laws.
ATLANTA, GA - October 27, 2026 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, today announced that it has entered into an unsecured $1,000,000 Revolving Loan Agreement dated October 23, 2026 (the “Revolving Loan Agreement”) with Bowery Consulting Group Inc. (the “Lender”). The revolving loan facility provides for advances of up to $1,000,000 (the “Revolving Loan”), with any advances subject to the Lender’s approval. The Revolving Loan bears interest at a rate of 12% per annum and matures 12 months from issuance. The Revolving Loan Agreement contains customary representations and warranties, indemnification provisions, and conditions precedent to borrowing. On October 23, 2026, Randal Chase, Dean Kollintzas, Nicole Lemerond, Jayne Morgan and John Spencer, Jr. resigned as directors of the Company, and Steven Brown, Tyler O’Brien and Manpreet Uppal were appointed as directors of the Company. Each of the newly appointed directors was nominated by the Lender pursuant to the Revolving Loan Agreement. Following these changes, the Company’s Board of Directors consists of five directors. The Board has determined that each of the newly appointed directors meet the independence standards of the Securities and Exchange Commission and Nasdaq. Following their appointment, Mr. O’Brien and Mr. Uppal will join the Audit Committee together with Dr. Robert McNally. David A. Dodd, Chairman and Chief Executive Officer of GeoVax, commented, “Securing this financing is an important achievement for GeoVax, reinforcing our balance sheet and providing the working capital needed to support our operations. I am pleased to welcome Steven, Tyler and Manpreet to our Board. Their diverse experience and strong leadership will bring fresh perspectives and valuable guidance as we continue to advance our GEO-MVA clinical program forward to what we believe will be an expedited pathway to commercialization. I would also like to express my deep appreciation to the departing Board members for their dedication and meaningful contributions to GeoVax’s journey. With strong leadership in place and a clear strategic path forward, we believe GeoVax is entering an exciting new chapter of growth and opportunity.” Further information concerning the Revolving Loan Agreement and the newly appointed directors of the Company will be contained in the Form 8-K to be filed with the Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on the development of vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers. GeoVax’s priority program is GEO-MVA, a Modified Vaccinia Ankara (MVA)–based vaccine targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in late 2026, to address critical global needs for expanded orthopoxvirus vaccine supply and biodefense preparedness. In oncology, GeoVax is developing Gedeptin®, a gene-directed enzyme prodrug therapy (GDEPT) designed to enhance immune checkpoint inhibitor activity. Gedeptin has completed a multicenter Phase 1/2 clinical trial in advanced head and neck cancer and is being advanced into combination strategies, including planned neoadjuvant and first-line settings. GeoVax maintains a global intellectual property portfolio supporting its infectious disease and oncology programs and continues to evaluate strategic partnerships and funding opportunities aligned with its development priorities. For more information, visit www.geovax.com. Forward-Looking Statements This release contains forward-looking statements regarding GeoVax’s business plans, the Revolving Loan Agreement and the availability of advances thereunder,. and the timing and outcome of its clinical development and regulatory activities. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, GeoVax is able to regain and maintain compliance with Nasdaq continued listing requirements, the timing of initiation and completion of the GEO-MVA Phase 3 trial and of any EMA marketing authorization, GeoVax's ability to continue as a going concern, the Lender permits GeoVax to draw down any portion of the loan commitment, which is subject to the Lender’s sole and absolute discretion, and whether the loan commitment is terminated, GeoVax is able to generate sufficient cash flow or raise additional capital to service, repay or refinance its indebtedness on acceptable terms or at all, GeoVax is able to comply with the covenants and other obligations in the Revolving Loan Agreement, including obtaining the Lender’s consent where required, an event of default occurs that results in the acceleration of GeoVax’s indebtedness or the exercise of other remedies by the Lender, GeoVax’s level of indebtedness limits its financial flexibility, operations or ability to pursue its business strategy or obtain additional financing, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: info@geovax.com 678-384-7220 Media Contact: Jessica Starman media@geovax.com